Can a Nevada resident get peptides by telehealth?
NRS 629.515 requires a provider at a distant site who uses telehealth to diagnose, manage care, or write a prescription for a patient in Nevada to hold a valid Nevada license or certificate (including a telemedicine license under NRS 630.261), subjects the provider to Nevada law, jurisdiction, and licensing board regulations wherever the provider is located, and states that the section does not expand scope of practice or authorize care that violates the standard of care. Under NRS 629.515(4), a provider may establish a relationship with a patient using telehealth when it is clinically appropriate to do so, and the State Board of Health may adopt regulations governing that process; the statute itself lists no further conditions such as a required in-person visit. Nevada defines telehealth as delivering services through information and audio-visual communication technology (excluding fax and email), including synchronous interaction, an asynchronous system of storing and forwarding information, and audio-only interaction, whether synchronous or asynchronous. Because the statute expressly includes asynchronous delivery and allows the relationship to be formed by telehealth, this record treats asynchronous prescribing as allowed when the standard of care is met. None of the peptides in this database are controlled substances. [2]
How does the Nevada pharmacy board treat compounding?
| Board | Nevada State Board of Pharmacy |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Nevada State Board of Pharmacy licenses pharmacists, pharmacies, and out-of-state pharmacies under NRS chapter 639 and adopts rules in NAC chapter 639. NRS 639.2328 provides that every pharmacy located outside Nevada that dispenses prescriptions to patients located in Nevada must be licensed by the Board, and to be licensed it must hold a pharmacy license in its home state, comply with applicable federal law, and name a responsible pharmacist. The Board's compounding rules are in NAC 639.661 to 639.690 (compounding and dispensing drug products): NAC 639.670 adopts the 2023 United States Pharmacopeia and National Formulary by reference, and NAC 639.67053 requires every pharmacist and technician who compounds sterile products to comply with USP chapter 797. Nevada has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [4] [5] [6] [8]
Can you get compounded GLP-1s in Nevada?
Nevada's broad telehealth definition makes app-based GLP-1 programs lawful on the prescribing side if the prescriber holds a Nevada license, and the dispensing pharmacy must be licensed by the Nevada State Board of Pharmacy. [1] [2] [11]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Nevada?
Verified access options
Prescriber licensed in Nevada, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Nevada. Asynchronous (questionnaire or messaging) prescribing is permitted when it meets the standard of care.
Pharmacy licensed or registered with the Nevada State Board of Pharmacy
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in Nevada
Is it legal to buy research peptides in Nevada?
Nevada's food and drug law (NRS chapter 585) prohibits selling adulterated or misbranded drugs, and NRS chapter 639 restricts dispensing of prescription drugs to licensed pharmacies and practitioners. [3] [7] [12]
Peptide-specific notes for Nevada
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including from a Nevada-licensed telehealth prescriber using synchronous or asynchronous telehealth under NRS 629.515. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [11] |
Frequently asked questions
Can I get a GLP-1 prescription in Nevada through an asynchronous telehealth app?
Nevada's definition of telehealth includes asynchronous store-and-forward and audio-only interaction, and a provider-patient relationship can be established through telehealth, so app-based care is allowed if the prescriber holds a Nevada license and meets the standard of care. [2]
Does a telehealth prescriber need a Nevada license?
Yes. NRS 629.515 requires a valid Nevada license or certificate to provide telehealth services to a patient located in Nevada, subject to narrow exceptions. [2]
Can an out-of-state pharmacy ship compounded peptides to me in Nevada?
Only if it is licensed by the Nevada State Board of Pharmacy. Search the Board's license verification before ordering. [1] [4]
Can a Nevada pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]Nevada State Board of Pharmacy
- [2]NRS 629.515, Telehealth: license required; establishment of relationship with patient
- [3]NRS chapter 639, Pharmacy
- [4]NRS 639.2328, Pharmacy located outside Nevada that dispenses prescriptions to patients located in Nevada: licensing
- [5]NAC 639.67053, Compounding standards (sterile compounded drug products, USP chapter 797)
- [6]NAC chapter 639, Pharmacy
- [7]NRS chapter 585, Food, drugs and cosmetics
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [12]21 U.S.C. 331, Prohibited acts
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in Nevada?. https://peptideagent.ai/legal/nevada- HTML link
<a href="https://peptideagent.ai/legal/nevada">Are peptides legal in Nevada?</a>, PeptideAgent, updated September 22, 2026.